Acadia Pharmaceuticals
|
14.72 |
|
0.15 |
1.03% |
-13.77% |
2025-04-17 |
Agios Pharmaceuticals
|
27.66 |
|
0.52 |
1.92% |
-6.01% |
2025-04-17 |
ALKERMES
|
27.00 |
|
-0.20 |
-0.74% |
13.64% |
2025-04-17 |
Alnylam Pharmaceuticals
|
234.56 |
|
4.06 |
1.76% |
61.59% |
2025-04-17 |
Amgen
|
276.99 |
|
-5.85 |
-2.07% |
5.41% |
2025-04-17 |
Biogen
|
118.54 |
|
3.28 |
2.84% |
-37.78% |
2025-04-17 |
BioMarin Pharmaceutical
|
59.17 |
|
0.35 |
0.60% |
-34.31% |
2025-04-17 |
Exelixis
|
36.20 |
|
0.05 |
0.14% |
60.96% |
2025-04-17 |
Incyte
|
58.21 |
|
0.48 |
0.83% |
10.27% |
2025-04-17 |
Ionis Pharmaceuticals
|
28.40 |
|
0.05 |
0.18% |
-30.41% |
2025-04-17 |
MacroGenics
|
1.26 |
|
0.08 |
6.78% |
-92.16% |
2025-04-17 |
Neurocrine Biosciences
|
101.46 |
|
1.36 |
1.36% |
-23.45% |
2025-04-17 |
Prothena
|
9.20 |
|
-0.06 |
-0.65% |
-55.27% |
2025-04-17 |
Ultragenyx Pharmaceutical
|
35.70 |
|
0.72 |
2.06% |
-17.70% |
2025-04-17 |
Regeneron Pharmaceuticals
|
562.95 |
|
12.98 |
2.36% |
-37.02% |
2025-04-17 |
Vertex Pharmaceuticals
|
488.67 |
|
2.46 |
0.51% |
24.19% |
2025-04-17 |